How Is The Faecal Extraction Systems Market Size Forecasted To Progress From 2026 To 2030?
The faecal extraction systems market size has grown strongly in recent years. It will grow from $1.7 billion in 2025 to $1.79 billion in 2026 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to increasing incidence of gastrointestinal infections, expansion of diagnostic laboratory networks, rising adoption of fecal biomarker testing, growth in parasitic disease screening, improved clinical awareness of gut health.
The faecal extraction systems market size is expected to see strong growth in the next few years. It will grow to $2.21 billion in 2030 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to increasing demand for early disease detection, rising investments in advanced diagnostic assays, expansion of outpatient diagnostic services, growing focus on preventive healthcare, increasing adoption of automated laboratory workflows. Major trends in the forecast period include increasing adoption of automated sample collection systems, rising demand for rapid stool diagnostics, growing use of immunological and molecular assays, expansion of point-of-care testing solutions, enhanced focus on diagnostic accuracy and hygiene.
Claim Your Free Report Sample Today:
Which Drivers Are Expected To Support The Future Advancement Of The Faecal Extraction Systems Market?
The increasing prevalence of inflammatory bowel disease is expected to propel the growth of the faecal extraction systems market going forward. Inflammatory bowel disease (IBD) is a category of illnesses characterized by long-term (chronic) inflammation of digestive system tissues. Faecal extraction systems are used for the diagnosis, monitoring of disease activity, treatment guidance, and prediction of disease relapse and post-operative recurrence in inflammatory bowel disease, as a result, the increasing prevalence of inflammatory bowel disease increases the demand for faecal extraction systems. For instance, in September 2023, according to the Impact of IBD Report 2023 published by the IBD Clinical and Research Centre, a Canada-based organization that aims to improve the lives of patients with Crohn's disease and ulcerative colitis, with a prevalence of 825 per 100,000 in 2023, over 320,000 people in Canada have inflammatory bowel disease (IBD), and as the prevalence is expected to increase by 2.44% annually, 1.1% of the population, or 470,000 Canadians, is projected to be living with IBD by 2035. Therefore, the increasing prevalence of inflammatory bowel disease in faecal extraction systems is expected drives the growth of the faecal extraction systems market.
Which Segment Categories Are Influencing The Growth Trajectory Of The Faecal Extraction Systems Market?
The faecal extraction systems market covered in this report is segmented –
1) By Assay: Calprotectin, Hemoglobin
2) By Analysis Test: Microscopic, Chemical, Immunological, Microbiological
3) By Indication: Parasitic Infection, Bacterial Indication, Poor Nutrient Absorption
4) By End-Use: Diagnostic Centers, Hospitals And Clinics
Subsegments:
1) By Calprotectin: Quantitative Calprotectin Assays, Qualitative Calprotectin Assays
2) By Hemoglobin: Fecal Occult Blood Tests (FOBT), Immunochemical Fecal Hemoglobin Tests
Which Trends Are Expected To Steer The Evolution Of The Faecal Extraction Systems Market?
Major companies operating in the faecal extraction system market are developing innovative products such as colorectal cancer (CRC) screening tests to meet larger customer bases, more sales, and increase revenue. Colorectal cancer (CRC) screening tests refer to diagnostic procedures designed to detect the presence of colorectal cancer or precancerous conditions in individuals who may not have symptoms. For instance, in November 2023, Guardant Health, a US-based diagnostics company, launched Shield, a blood-based colorectal cancer (CRC) screening test. Specifically, Shield assay distinguishes itself by identifying particular DNA characteristics that could signify the presence of cancer. Its efficacy in detecting colorectal cancer in average-risk individuals was substantiated through the ECLIPSE registrational study, involving over 20,000 participants in the United States.
Which Organizations Are Considered Principal Leaders In The Faecal Extraction Systems Market?
Major companies operating in the faecal extraction systems market are Alpha Laboratories Ltd., Arbor Assays, Buhlmann Laboratories AG, Calpro AS, DRG Instruments GmbH, Biohit Healthcare Ltd., Meridian Bioscience Inc., Quidel Corporation, DiaSorin SpA, Sekisui Diagnostics LLC, Abbott Laboratories, Roche Diagnostics Corporation, Randox Laboratories Ltd., Trinity Biotech plc, bioMérieux SA, Werfen SA, Mobidiag Oy, Hologic Inc., Siemens Healthineers, Beckman Coulter Inc., Thermo Fisher Scientific Inc.
Get Your In-Depth Faecal Extraction Systems Market Report Now:
Which Geographical Areas Are Expected To Witness The Most Substantial Faecal Extraction Systems Market Expansion Ahead?
North America was the largest region in the faecal extraction systems market in 2025. The regions covered in the faecal extraction systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: Market Research Reports
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment